Santen Ventures, based in Emeryville, California, is a wholly-owned subsidiary of Santen Holdings. The company is dedicated to investing in promising seed-stage firms that are developing innovative technologies, particularly in the field of eye care and pharmaceuticals. Their core mission is to advance eye health and vision by supporting groundbreaking innovations that can lead to new treatments and therapies. Santen Ventures focuses on identifying and nurturing early-stage companies that have the potential to make significant contributions to the healthcare market.
Notable affiliated individuals include executives from Santen Holdings, who bring extensive experience in the pharmaceutical industry. Key investors are primarily from Santen Holdings, ensuring strong financial backing and strategic guidance. Among their achievements, Santen Ventures has successfully identified and invested in several pioneering startups that have gone on to develop impactful eye care solutions. The overall impact of Santen Ventures is seen in their contribution to advancing medical technology and improving patient outcomes in the field of ophthalmology.
Santen Ventures - Similar Companies
Santen Ventures - Quick Facts
Who are Santen Ventures' competitors?
Companies similar to Santen Ventures include Sorrento Ventures, Secure Ventures, P74 Ventures and Carrier Ventures.
When was Santen Ventures founded?
Santen Ventures was founded in 2017.
Where is Santen Ventures' headquarters located?
Santen Ventures' headquarters is located in Emeryville, CA, US.
How much disclosed funding has Santen Ventures raised?
As of Sep 1, 2011, Santen Ventures has disclosed funding of €59M (EUR). Undisclosed round amounts are excluded.
How many employees does Santen Ventures have?
Santen Ventures - Classification
- Ownership
- Technology
- Revenue
